+++
title = "Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications 笔记目录"
date = 2025-09-19
[taxonomies]
category = ["笔记"]
field = ["医学", "药理学", "精神药理学"]
+++

* [1 Chemical Neurotransmission 化学神经传导](/blog/20250919-psychopharmacology-note-chapter-1)
    * [1.1 Anatomical versus Chemical Basis of Neurotransmission 神经传导的基础：从解剖学到化学](/blog/20250919-psychopharmacology-note-chapter-1/#1-1-anatomical-versus-chemical-basis-of-neurotransmission-shen-jing-chuan-dao-de-ji-chu-cong-jie-pou-xue-dao-hua-xue)
    * [1.2 Principles of Chemical Neurotransmission 化学神经传导的原理](/blog/20250919-psychopharmacology-note-chapter-1/#1-2-principles-of-chemical-neurotransmission-hua-xue-shen-jing-chuan-dao-de-yuan-li)
    * [1.3 Signal Transduction Cascades 信号转导](/blog/20250919-psychopharmacology-note-chapter-1/#1-3-signal-transduction-cascades-xin-hao-zhuan-dao)
    * [1.4 Epigenetics 表观遗传](/blog/20250919-psychopharmacology-note-chapter-1/#1-4-epigenetics-biao-guan-yi-chuan)
    * [1.5 A Brief Word about RNA RNA简介](/blog/20250919-psychopharmacology-note-chapter-1/#1-5-a-brief-word-about-rna-rnajian-jie)
* [2 Transporters, Receptors, and Enzymes as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的转运体、受体和酶](/blog/20250919-psychopharmacology-note-chapter-2)
    * [2.1 Neurotransmitter Transporters as Targets of Drug Action 递质转运体作为药靶点](/blog/20250919-psychopharmacology-note-chapter-2/#2-1-neurotransmitter-transporters-as-targets-of-drug-action-di-zhi-zhuan-yun-ti-zuo-wei-yao-ba-dian)
    * [2.2 G-Protein-Linked Receptors G蛋白耦联受体](/blog/20250919-psychopharmacology-note-chapter-2/#2-2-g-protein-linked-receptors-gdan-bai-ou-lian-shou-ti)
    * [2.3 Enzymes as Sites of Psychopharmacological Drug Action 酶作为精神药理学药靶点](/blog/20250919-psychopharmacology-note-chapter-2/#2-3-enzymes-as-sites-of-psychopharmacological-drug-action-mei-zuo-wei-jing-shen-yao-li-xue-yao-ba-dian)
    * [2.4 Cytochrome P450 Drug Metabolizing Enzymes as Targets of Psychotropic Drugs 药代谢酶CYP450作为精神药靶点](/blog/20250919-psychopharmacology-note-chapter-2/#2-4-cytochrome-p450-drug-metabolizing-enzymes-as-targets-of-psychotropic-drugs-yao-dai-xie-mei-cyp450zuo-wei-jing-shen-yao-ba-dian)
* [3 Ion Channels as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的离子通道](/blog/20251021-psychopharmacology-note-chapter-3/)
    * [3.1 Ligand-Gated Ion Channels as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的配体门控离子通道](/20251021-psychopharmacology-note-chapter-3/#3-1-ligand-gated-ion-channels-as-targets-of-psychopharmacological-drug-action-zuo-wei-jing-shen-yao-li-xue-yao-ba-dian-de-pei-ti-men-kong-chi-zi-tong-dao)
    * [3.2 Voltage-Sensitive Ion Channels as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的电敏离子通道](/blog/20251021-psychopharmacology-note-chapter-3/#3-2-voltage-sensitive-ion-channels-as-targets-of-psychopharmacological-drug-action-zuo-wei-jing-shen-yao-li-xue-yao-ba-dian-de-dian-min-chi-zi-tong-dao)
    * [3.3 Ion Channels and Neurotransmission 离子通道和神经传输](/blog/20251021-psychopharmacology-note-chapter-3/#3-3-ion-channels-and-neurotransmission-chi-zi-tong-dao-he-shen-jing-chuan-shu)
* [4 Psychosis, Schizophrenia, and the Neurotransmitter Networks Dopamine, Serotonin, and Glutamate 精神病性症状、精神分裂症以及多巴胺、5-HT和谷氨酸的神经递质网络](/blog/20251106-psychopharmacology-note-chapter-4/)
    * [4.1 Symptoms of Psychosis 精神病性症状](/blog/20251106-psychopharmacology-note-chapter-4/#4-1-symptoms-of-psychosis-jing-shen-bing-xing-zheng-zhuang)
    * [4.2 The Three Major Hypotheses of Psychosis and Their Neurotransmitter Networks 精神病性症状的3主要假说及其神经递质网络](/blog/20251106-psychopharmacology-note-chapter-4/#4-2-the-three-major-hypotheses-of-psychosis-and-their-neurotransmitter-networks-jing-shen-bing-xing-zheng-zhuang-de-3zhu-yao-jia-shuo-ji-qi-shen-jing-di-zhi-wang-luo)
    * [4.3 The Classic Dopamine Hypothesis of Psychosis and Schizophrenia 精神病性症状和精神分裂症的经典多巴胺假说](=/blog/20251106-psychopharmacology-note-chapter-4/#4-3-the-classic-dopamine-hypothesis-of-psychosis-and-schizophrenia-jing-shen-bing-xing-zheng-zhuang-he-jing-shen-fen-lie-zheng-de-jing-dian-duo-ba-e-jia-shuo)
    * [4.4 The Glutamate Hypothesis of Psychosis and Schizophrenia 精神病性症状和精神分裂症的谷氨酸假说](/blog/20251106-psychopharmacology-note-chapter-4/#4-4-the-glutamate-hypothesis-of-psychosis-and-schizophrenia-jing-shen-bing-xing-zheng-zhuang-he-jing-shen-fen-lie-zheng-de-gu-an-suan-jia-shuo)
    * [4.5 The Serotonin Hypothesis of Psychosis and Schizophrenia 精神病性症状和精神分裂症的5-HT假说](/blog/20251106-psychopharmacology-note-chapter-4/#4-5-the-serotonin-hypothesis-of-psychosis-and-schizophrenia-jing-shen-bing-xing-zheng-zhuang-he-jing-shen-fen-lie-zheng-de-5-htjia-shuo)
    * [4.6 Schizophrenia as the Prototypical Psychotic Disorder 精神分裂症作为典型精神病性障碍](/blog/20251106-psychopharmacology-note-chapter-4/#4-6-schizophrenia-as-the-prototypical-psychotic-disorder-jing-shen-fen-lie-zheng-zuo-wei-dian-xing-jing-shen-bing-xing-zhang-ai)
    * [4.7 Other Psychotic Illnesses 其他精神病性障碍](/blog/20251106-psychopharmacology-note-chapter-4/#4-7-other-psychotic-illnesses-qi-ta-jing-shen-bing-xing-zhang-ai)
* 5 Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called "Antipsychotics" 作用于多巴胺和5-HT受体治疗精神病性障碍和心境障碍等的“抗精神病药”
* 6 Mood Disorders and the Neurotransmitter Networks Norepinephrine and γ-Aminobutyric Acid (GABA) 心境障碍以及去甲肾上腺素和GABA的神经递质网络
* 7 Treatment for Mood Disorders: So-Called "Antidepressants" and "Mood Stabilizers" 治疗心境障碍的“抗抑郁药”和“心境稳定药”
* 8 Anxiety, Trauma, and Treatment 焦虑和创伤及其治疗
* 9 Chronic Pain and Its Treatment 慢性疼痛及其治疗
* 10 Disorders of Sleep and Wakefulness and Their Treatment: Neurotransmitter Networks for Histamin and Orexin 睡眠觉醒障碍、其治疗以及组胺和食欲素的神经递质网络
* 11 Attention Deficit Hyperactivity Disorder and Its Treatment 注意缺陷多动障碍及其治疗
* 12 Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine 痴呆的病因、对症治疗以及乙酰胆碱的神经递质网络
* 13 Impulsivity, Compulsivity, and Addiction 冲动、强迫和成瘾
